Skip to content

Conrad Pharma

Active
Private limited companyfounded 2013active for 13 yearsDiependale 8, 9700 Oudenaarde, BelgiumKBO/BCE: BE 0536.875.697

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
28-08
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 28 days late
2025
29-08
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 29 days late
2024
12-07
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 19 days before the deadline
24-01
Gazette deed Appointments: VERZELE Philippe Christophe Angèle Joseph (statutair bestuurder) and PLUYM Vanessa Annick Isidora (statutair bestuurder)
Purpose change · Legal-form conversion · Capital conversion10 points ▸
  • General meeting, 21-12-2023
  • Purpose change
  • Other provision, “onderworpenheid aan dwingende bepalingen van het Wetboek van vennootschappen en verenigingen”, 01-01-2020 (deed in Dutch)
  • Legal-form conversion, “besloten vennootschap” (deed in Dutch)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Reserve release, “opheffing, middelen beschikbaar voor uitkering” (deed in Dutch)
  • Amendment of the articles, mentioned 3 times in the deed
  • Director appointment, VERZELE Philippe Christophe Angèle Joseph (statutair bestuurder)
  • Director appointment, PLUYM Vanessa Annick Isidora (statutair bestuurder)
  • Power of attorney

Open the act in the Belgian Official Gazette

2023
31-12
Financial Equity above €1mequity €1.1m ▲17.8%
With a profit in every financial year since 2018, equity grows to €1.1m.
05-07
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 26 days before the deadline
2022
31-12
Financial Highest result from 2018 to 2025net €295,505 ▲56.1%
The operating result of €314,497 and the net result of €295,505 are both a record.
25-08
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 25 days late
2021
31-12
Financial Equity above €500,000equity €600,467 ▲46.1%
With a profit in every financial year since 2018, equity grows to €600,467.
16-09
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 47 days late
2020
14-09
NBB filing Annual accounts 2019 filedPDF
abbreviated format · 45 days late
2019
31-12
Financial Equity above €200,000equity €259,355 ▲95.1%
With a profit in every financial year since 2018, equity grows to €259,355.
Show earlier events
23-09
NBB filing Annual accounts 2018 filedPDF
abbreviated format · 54 days late
2018
31-08
NBB filing Annual accounts 2017 filedPDF
micro format · 31 days late
2017
07-07
NBB filing Annual accounts 2016 filedPDF
micro format · 24 days before the deadline
2013
01-08
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 23 July 2013, Conrad Pharma was incorporated.1 Total assets went from €3.4m in 2018 to €5.0m in 2025 and headcount from 2.9 to 2.5 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Next steps